Teradici closes $17 Million strategic funding with leading service provider

Company:
Teradici Corporation
Deal Amount:
$17Million

TELUS investment part of Teradici’s new US $17 million funding round

Burnaby, British Columbia April 7, 2009 – Teradici Corporation, the industry leader in delivering a true PC experience over standard IP networks, today announced completion of a US $17 million series C funding round for its PC-over-IP network-delivered computing technology. With network-delivered computing, users can work at inexpensive computer stations at any site, with all operating systems, applications, and data residing in central datacenters.

Ondine Announces $400,000 Loan from Insider

Company:
Ondine Biopharma Corporation
Deal Amount:
$0Million

VANCOUVER, BC, April 6, 2009 – Ondine Biopharma Corporation (the “Company” or “Ondine”, TSX: OBP; AIM: OBP) a medical technology company developing photodisinfection based products, today announced that it has entered into a loan agreement with Carolyn Cross, Chairman, CEO and a shareholder of the Company, pursuant to which Ms. Cross has advanced the Company C$400,000 (the “Loan”), demonstrating continued support of the Company. Ms.

Con-Space Announces $1.1 Million Equity Financing

Company:
CON-SPACE Communications
Deal Amount:
$1Million

CON-SPACE Communications Ltd. (the “Company” or “CON-SPACE”) (TSX-V: CCB), today announced that it is proceeding with a private placement of 22,000,000 common shares at $0.05 each, for gross proceeds of $1,100,000, to Turret Oy Ab (“Turret”), its largest shareholder and secured lender. Completion of the private placement is subject to regulatory approval and is subject to completion of a proposed restructuring to address the Company’s current serious financial difficulties.

Lignol Announces Closing of Final Tranche of $1 Million Private Placement

Company:
Lignol Energy Corporation
Deal Amount:
$1Million

VANCOUVER, April 1 - Lignol Energy Corporation (TSX-V: LEC) ("Lignol" or "the Company"), a leading technology company in the cellulosic ethanol and biorefining sector, today announced that it has completed the second and final tranche of the non-brokered private placement that was previously announced on February 12, 2009. Under this second tranche, the Company issued 2,047,885 common shares for gross proceeds of $839,632.85.

Neovasc To Raise $2 Million In Non-Brokered Private Placement

Company:
Neovasc Inc.
Deal Amount:
$2Million

Proceeds Will Advance Key New Products Including Completing CE Mark Application for the Reducer™ Stent

Lignol Project Awarded $1.82 Million in Additional Funding from SDTC

Company:
Lignol Energy Corporation
Deal Amount:
$1Million

Vancouver, B.C. – March 19, 2009 – Lignol Energy Corporation (TSX-V: LEC) (“Lignol” or “the Company”), a leading technology company in the cellulosic ethanol and biorefining sector, today announced that a project led by its wholly-owned subsidiary, Lignol Innovations Ltd., has been awarded up to $1.82 million in additional funding contributions from Sustainable Development Technology Canada (SDTC).

Zeugma Announces $9 Million Series C Funding;Total Funding Approaches $50 Million

Company:
Zeugma Systems Inc
Deal Amount:
$9Million

Company Will Use New Funding for Global Expansion of Sales and Marketing, Continued R&D

Angiotech Pharmaceuticals, Inc. Announces New $10 Million Senior Secured Term Loan And Credit Facilities

Company:
Angiotech Pharmaceuticals, Inc.
Deal Amount:
$10Million

Angiotech Pharmaceuticals, Inc. (NASDAQ: ANPI, TSX: ANP) today announced it has obtained a new Senior Secured Term Loan and Revolving Credit Facility. Wells Fargo Foothill, LLC is the sole arranger, administrative agent and lender for both the Term Loan and Revolving Credit Facility.

GenoLogics Completes Additional $5 Million Financing to Accelerate Translational Research Informatics Growth

Company:
GenoLogics Life Sciences Software
Deal Amount:
$5Million

Victoria, British Columbia - February 25, 2009 - GenoLogics has completed $5 million in financing, which will be applied towards ongoing expansion plans.

The latest round of financing was led by OVP Venture Partners of Seattle with support from Growth Works and Yaletown Venture Partners of Vancouver. The funds will be used to accelerate development and global deployment of an end-to-end informatics solution for organizations pursuing translational research initiatives.

Ondine Biopharma Announces $100,000 Private Placement Equity Financing

Company:
Ondine Biopharma Corporation
Deal Amount:
$0Million

Vancouver, Canada – February 23, 2009 - Ondine Biopharma Corporation (TSX: OBP; AIM: OBP) (the “Company”) a medical technology company developing photodisinfection based products, today announced it has closed the second tranche of its previously announced non-brokered private placement by issuing 1,650,168 common shares at a price of $0.06 per share for aggregate gross proceeds of C$99,010 to qualified investors pursuant to applicable exemptions.

Syndicate content